Published in Aliment Pharmacol Ther on July 01, 2002
A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut (2006) 2.33
Functional GI disorders: from animal models to drug development. Gut (2007) 1.55
Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol (2008) 1.52
Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci (2014) 1.47
Stress and visceral pain: from animal models to clinical therapies. Exp Neurol (2011) 1.25
Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.18
Pharmacology of serotonin: what a clinician should know. Gut (2004) 1.02
Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag (2008) 1.00
Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol (2004) 0.96
Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities. Front Psychiatry (2015) 0.96
Updates on treatment of irritable bowel syndrome. World J Gastroenterol (2008) 0.94
Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis (2009) 0.93
Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study. Aliment Pharmacol Ther (2008) 0.91
LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil (2010) 0.89
Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature. Curr Rheumatol Rev (2016) 0.88
Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders. Aliment Pharmacol Ther (2015) 0.87
Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes (2009) 0.87
Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol (2013) 0.86
The treatment of irritable bowel syndrome. Therap Adv Gastroenterol (2009) 0.84
Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol (2012) 0.82
Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials. PLoS One (2017) 0.82
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil (2016) 0.79
Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil (2016) 0.75
The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D). Therap Adv Gastroenterol (2015) 0.75
Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest (1999) 7.69
A novel class of evolutionarily conserved genes defined by piwi are essential for stem cell self-renewal. Genes Dev (1998) 6.74
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry (2001) 4.13
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet (1998) 4.05
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest (2001) 3.86
Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J Clin Invest (1979) 3.61
Retinal damage by light in rats. Invest Ophthalmol (1966) 3.52
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Getting evidence into clinical practice: an organisational behaviour perspective. J Health Serv Res Policy (2000) 3.06
Properties of a temperature-sensitive radiation-sensitive mutant of Escherichia coli. Proc Natl Acad Sci U S A (1968) 3.02
High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol (1998) 2.77
JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther (2005) 2.71
Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med (1986) 2.63
Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol (1995) 2.62
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev (1999) 2.56
Isolation and characterization of new fission yeast cytokinesis mutants. Genetics (1998) 2.51
Western equine encephalomyelitis vaccine produced in chick embryo cell cultures. Appl Microbiol (1966) 2.48
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology (2000) 2.26
V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2001) 2.19
Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials. Aliment Pharmacol Ther (2014) 2.17
Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J Neurochem (2001) 2.14
Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst (2001) 2.12
The effect of discharge pack formula and breast pumps on breastfeeding duration and choice of infant feeding method. Birth (1997) 2.08
Properties of a temperature-sensitive, radiation-sensitive mutant of Escherichia coli. II. DNA replication. Proc Natl Acad Sci U S A (1969) 2.07
BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int (2006) 2.05
Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol Cell Biol (1996) 1.97
Prospective comparison treatment of 595-nm pulsed-dye lasers for virgin port-wine stain. Br J Dermatol (2015) 1.96
Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology (1997) 1.94
Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. J Infect Dis (1987) 1.90
Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. J Infect Dis (1978) 1.86
The dimensions of DNA in solution. J Mol Biol (1981) 1.80
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology (1997) 1.78
The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale. Aliment Pharmacol Ther (2004) 1.76
Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology (2009) 1.76
Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry (2001) 1.69
Respiratory rate: measurement of variability over time and accuracy at different counting periods. Arch Dis Child (1991) 1.68
Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci U S A (2001) 1.68
Immediate-early RNA 2.9 and early RNA 2.6 of bovine herpesvirus 1 are 3' coterminal and encode a putative zinc finger transactivator protein. J Virol (1992) 1.66
Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation (1998) 1.65
Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study. Aliment Pharmacol Ther (2012) 1.64
Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis. Genes Immun (2006) 1.64
Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med (2001) 1.64
Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol (2001) 1.63
Review article: the treatment of functional abdominal bloating and distension. Aliment Pharmacol Ther (2011) 1.63
The role of the sid1p kinase and cdc14p in regulating the onset of cytokinesis in fission yeast. EMBO J (2000) 1.62
Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients. Neurology (2002) 1.61
fMRI-acoustic noise alters brain activation during working memory tasks. Neuroimage (2005) 1.60
Attention to pain localization and unpleasantness discriminates the functions of the medial and lateral pain systems. Eur J Neurosci (2005) 1.60
Some limits to evidence-based medicine: a case study from elective orthopaedics. Qual Health Care (1999) 1.57
Conductivities of three-layer live human skull. Brain Topogr (2002) 1.57
Functional GI disorders: from animal models to drug development. Gut (2007) 1.55
Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil (2013) 1.55
Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. Am J Psychiatry (2001) 1.52
Genital Chlamydia infections in sexually active female adolescents: do we really need to screen everyone? J Adolesc Health (1997) 1.50
Alcohol use and pregnancy: improving identification. Obstet Gynecol (1998) 1.50
Evaluation of a new cephalosporin antibiotic, cephapirin. Antimicrob Agents Chemother (1972) 1.50
Identification of conserved, RpoS-dependent stationary-phase genes of Escherichia coli. J Bacteriol (1998) 1.49
Chromosomal translocation (1:13) in a case of alveolar rhabdomyosarcoma. J Pediatr Hematol Oncol (1998) 1.48
Brain areas specific for attentional load in a motion-tracking task. J Cogn Neurosci (2001) 1.48
Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment Pharmacol Ther (2012) 1.47
Gender-related differences in IBS symptoms. Am J Gastroenterol (2001) 1.47
In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci (1996) 1.46
Severity in irritable bowel syndrome: a Rome Foundation Working Team report. Am J Gastroenterol (2011) 1.46
Neonates born to pre-eclamptic mothers have a higher percentage of natural killer cells (CD3-/CD56+16+) in umbilical cord blood than those without pre-eclampsia. J Matern Fetal Neonatal Med (2003) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
Autoantibodies in systemic vasculitis. Aust N Z J Med (1991) 1.44
A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J Biol Chem (1999) 1.43
Rapid diagnosis of Chlamydia trachomatis pneumonia in infants by direct immunofluorescence microscopy of nasopharyngeal secretions. J Pediatr (1986) 1.43
Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis. Neuroimage (2008) 1.43
Practice-induced changes of brain function during visual attention: a parametric fMRI study at 4 Tesla. Neuroimage (2004) 1.42
Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil (2008) 1.41
Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort. Pediatrics (2000) 1.41
Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients. Am J Gastroenterol (2000) 1.38
National Practitioner Data Bank highlights risk management meeting. QRB Qual Rev Bull (1989) 1.38
Substance abuse among patients presenting at an inner-city psychiatric emergency room. Hosp Community Psychiatry (1993) 1.38
p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol Cell Biol (1997) 1.37
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol (1992) 1.37
The three major immediate-early transcripts of bovine herpesvirus 1 arise from two divergent and spliced transcription units. J Virol (1991) 1.37
Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut (2005) 1.37
Fragmented condensate ground state of trapped weakly interacting bosons in two dimensions. Phys Rev Lett (2001) 1.36
Progressive right frontotemporal degeneration: clinical, neuropsychological and SPECT characteristics. Dementia (1993) 1.35
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study. Neurology (2001) 1.35
Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. Int J STD AIDS (1999) 1.34
Gender differences in the functional organization of the brain for working memory. Neuroreport (2000) 1.33